Drilldown: Medicines
Appearance
Medicines > fda max
:
80 mg/d
or
Formulation-dependent
& onset:
Triglyceride lowering at 4-8 weeks; CV benefit emerges over months 
:
80 mg/d
or
Formulation-dependent
& onset:
Triglyceride lowering at 4-8 weeks; CV benefit emerges over months 
Use the filters below to narrow your results.
There are no results for this report.

